Clinical Trials in Cinisello Balsamo, Italy
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
BRING-UP 3 Heart Failure
Heart Failure
Heart Care Foundation10,000 enrolled187 locationsNCT06279988